Welcome to our dedicated page for Cinemark Holdings SEC filings (Ticker: CNK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cinemark Holdings, Inc. filings document the public-company disclosures of a global motion picture exhibitor listed on the NYSE under CNK. Its reports include operating results furnished on Form 8-K, Regulation FD disclosures, earnings exhibits and updates on revenue categories, profitability measures, box office performance, concession activity and capital expenditures for its theater circuit.
Other filings cover governance and compensation matters in the definitive proxy statement, common-stock dividends, share repurchase authorization, credit agreement amendments involving Cinemark USA, Inc., and agreements related to convertible senior notes and warrants. The filing record also documents capital structure, board actions, shareholder matters and material events affecting the company’s financing and corporate governance.
Cinemark Holdings, Inc. (CNK) has a notice under Rule 144 filed on behalf of officer Valmir Fernandes, as trustee of the VF Trust, covering a proposed sale of 58,000 shares of common stock through Charles Schwab & Co., Inc. at an aggregate market value of $2,040,127. The notice references underlying equity compensation awards from restricted stock lapses and RSAs/PSUs in February 2025 and discloses that 30,000 shares were sold on June 11, 2026 for proceeds of $1,005,150, with 115,911,855 shares of Cinemark common stock outstanding.
Cinemark Holdings, Inc. (CNK) reported that officer Valmir Fernandes, President – Cinemark International, disposed of 20,000 shares of Common Stock on September 11, 2026 in a disposition to the issuer through VF Trust, an indirect ownership vehicle. The reported price of $35.17 per share is a weighted average sale price for the shares, and the filing affirms the transactions were made under a Rule 10b5-1 trading plan. Following this transaction, VF Trust held 106,386 shares indirectly, and Fernandes also held 37,515 shares directly.
Cinemark Holdings, Inc. (CNK) insider Michael Cavalier, EVP–General Counsel, reported an indirect disposition to the issuer of 107,296 shares of common stock on September 1, 2026 through the Cavalier Revocable Trust at a weighted average sale price of $35.02 per share, under a Rule 10b5-1 trading plan. Following this transaction, the trust held 223,385 shares indirectly and Cavalier also held 42,273 shares directly.
Cinemark Holdings, Inc. (CNK) received a Rule 144 notice related to a planned sale of its common stock for the account of Michael Cavalier, an officer, through the Cavalier Revocable Trust. The notice covers 107,296 shares with an aggregate market value of $3,757,078.00, versus 115,911,855 shares outstanding as of September 1, 2026. The shares derive from equity compensation awards, including RSAs and PSUs granted between 2014 and 2025.
Cinemark Holdings, Inc. (CNK) reported that Chief Executive Officer Sean Gamble, through the Joint Revocable Trust of Sean Robert Gamble & Luminita Spetcu, disposed of 7,191 shares of common stock to the issuer on August 31, 2026 at a weighted average sale price of $35.99 per share, under a Rule 10b5-1 trading plan. Following this transaction, the trust held 439,487 shares indirectly, and Gamble also held 219,284 shares directly.
Cinemark Holdings, Inc. (CNK) reported that Chief Executive Officer Sean Gamble, through the Joint Revocable Trust of Sean Robert Gamble & Luminita Spetcu, disposed of 138,884 shares of common stock in a transaction coded as a disposition to the issuer. The reported $38.19 figure is a weighted average sale price for the shares. After this transaction, the trust held 446,678 shares indirectly, and Gamble also held 219,284 shares directly. The filing affirms that the transaction was effected under a Rule 10b5-1 trading plan.
Cinemark Holdings, Inc. (CNK) received a notice that officer Sean Gamble intends to sell up to 146,075 shares of Cinemark common stock under Rule 144 through broker Charles Schwab. The planned sale has an aggregate market value of $5,578,619, versus 115,911,855 shares outstanding. The shares derive from equity compensation awards that lapsed in 2025 and are held in the Joint Revocable Trust of Sean R. Gamble & Luminita Spetcu; sales may occur over various dates.
Cinemark Holdings, Inc. (CNK) reported that EVP, Chief Financial Officer Thomas Melissa disposed of 38,236 shares of common stock on 2026-08-20 in a disposition to the issuer. The transaction used a weighted average sale price of $37.53 per share, and Melissa now holds 129,076 shares directly. The transaction is affirmed as made under a Rule 10b5-1 trading plan.
Cinemark Holdings, Inc. (CNK) has a notice of proposed sale of securities filed under Rule 144 for shares beneficially owned by officer Melissa Thomas. J.P. Morgan Securities LLC is identified as the broker and signs as agent and attorney-in-fact for Melissa Thomas.
The notice covers Cinemark common stock that will be available for sale following RSA vesting events. These include 16,153 shares tied to vesting on February 23, 2025 and 22,083 shares tied to vesting on November 8, 2025, both described as compensation-related common stock.
Humrichouse Ximena G reported acquisition or exercise transactions in this Form 4 filing.
Cinemark Holdings director Ximena G Humrichouse received an annual grant of 5,439 shares of common stock on 2026-06-15 as a restricted stock award under the director compensation policy. The award carried a $0.00 grant price and $0.001 par value per share, increasing her direct holdings to 57,222 shares.